Related references
Note: Only part of the references are listed.Cisplatin-induced neurotoxicity involves the disruption of serotonergic neurotransmission
Anna Wellenberg et al.
PHARMACOLOGICAL RESEARCH (2021)
Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance
Marco Tigano et al.
NATURE (2021)
DAZAP2 acts as specifier of the p53 response to DNA damage
Magdalena C. Liebl et al.
NUCLEIC ACIDS RESEARCH (2021)
The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Lin Zhou et al.
CURRENT DRUG TARGETS (2020)
Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia
Manon Lernoux et al.
BIOCHEMICAL PHARMACOLOGY (2020)
PARP and PARG inhibitors in cancer treatment
Dea Slade
GENES & DEVELOPMENT (2020)
DNA damage invokes mitophagy through a pathway involving Spata18
Xiuli Dan et al.
NUCLEIC ACIDS RESEARCH (2020)
Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
Kinga Salat
PHARMACOLOGICAL REPORTS (2020)
Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy
Kinga Salat
PHARMACOLOGICAL REPORTS (2020)
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
B. Jordan et al.
ANNALS OF ONCOLOGY (2020)
Anticancer drug and ionizing radiation-induced DNA damage differently influences transcription activity and DDR-related stress responses of an endothelial monolayer
Verena Ziegler et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer
Debarati Banik et al.
CANCER RESEARCH (2020)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
Jaione Auzmendi-Iriarte et al.
CELL DEATH & DISEASE (2020)
A C. elegans model for neurodegeneration in Cockayne syndrome
Amanda F. C. Lopes et al.
NUCLEIC ACIDS RESEARCH (2020)
Vincristine-induced peripheral neuropathy: A mini-review
Gui-zhou Li et al.
NEUROTOXICOLOGY (2020)
Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
Angela De Simone et al.
CHEMMEDCHEM (2019)
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
Alan P. Kozikowski et al.
ACS CHEMICAL NEUROSCIENCE (2019)
The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
Justine Habibian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Enhancing the effect of immunotherapy by inhibiting tumor promoting effect of HDAC6
Debarati Banik et al.
CANCER RESEARCH (2019)
Primary neurons can enter M-phase
Chaska C. Walton et al.
SCIENTIFIC REPORTS (2019)
Beyond Symptomatic Relief for Chemotherapy-Induced Peripheral Neuropathy: Targeting the Source
Jiacheng Ma et al.
CANCER (2018)
Complex neuroprotective and neurotoxic effects of histone deacetylases
Elizabeth A. Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth
Lawrence Van Helleputte et al.
NEUROBIOLOGY OF DISEASE (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
HDAC inhibition improves autophagic and lysosomal function to prevent loss of subcutaneous fat in a mouse model of Cockayne syndrome
Marc Majora et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT)
Bengt Glimelius et al.
ACTA ONCOLOGICA (2018)
The C-elegans model in toxicity testing
Piper Reid Hunt
JOURNAL OF APPLIED TOXICOLOGY (2017)
Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells
Jianyun Zhao et al.
ONCOTARGET (2017)
Axon regeneration in C. elegans: Worming our way to mechanisms of axon regeneration
Alexandra B. Byrne et al.
EXPERIMENTAL NEUROLOGY (2017)
Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons
Markus Leo et al.
EXPERIMENTAL NEUROLOGY (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines
Katharina Stenzel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cisplatin induces protective autophagy through activation of BECNI in human bladder cancer cells
Ji-Fan Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Hana Starobova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
An enhanced C. elegans based platform for toxicity assessment
Huajiang Xiong et al.
SCIENTIFIC REPORTS (2017)
Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans
Edward F. Griffin et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic/therapeutic strategies and directions for future research
Wolfgang Grisold et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
C-elegans as a model system to accelerate discovery for Parkinson disease
Bryan A. Martinez et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Caenorhabditis elegans as a powerful alternative model organism to promote research in genetic toxicology and biomedicine
Sebastian Honnen
ARCHIVES OF TOXICOLOGY (2017)
Mitigating effect of EUK-207 on radiation-induced cognitive impairments
J. Raber et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
E. Conrad et al.
CELL DEATH AND DIFFERENTIATION (2016)
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity
Hong Zhan et al.
CARDIOVASCULAR RESEARCH (2016)
Upregulation of AMWAP: a novel mechanism for HDAC inhibitors to protect against cisplatin nephrotoxicity
Jinhua Tang et al.
KIDNEY INTERNATIONAL (2016)
DNA damage response in nephrotoxic and ischemic kidney injury
Mingjuan Yan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
Wenjun Zhou et al.
PLOS ONE (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents
Jiang Bian et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Calcium-related Neurotoxicity of Oxaliplatin: Understanding the Mechanisms to Drive Therapy
Paola Marmiroli et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Chemotherapy-induced peripheral neurotoxicity
Guido Cavaletti et al.
CURRENT OPINION IN NEUROLOGY (2015)
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models
Valentina Alda Carozzi et al.
EXPERIMENTAL NEUROLOGY (2015)
ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1
Benjamin A. Hilton et al.
MOLECULAR CELL (2015)
D-Methionine Protects Against Cisplatin-Induced Neurotoxicity in the Hippocampus of the Adult Rat
Sneha Hinduja et al.
NEUROTOXICITY RESEARCH (2015)
Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
Alessia Chiorazzi et al.
TOXICS (2015)
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Annalisa Canta et al.
TOXICS (2015)
Chemotherapy-induced neuropathy: A comprehensive survey
N. C. Miltenburg et al.
CANCER TREATMENT REVIEWS (2014)
Targeting ATR in DNA damage response and cancer therapeutics
Emmanouil Fokas et al.
CANCER TREATMENT REVIEWS (2014)
Lysine Deacetylase (KDAC) Regulatory Pathways: an Alternative Approach to Selective Modulation
Michael W. Van Dyke
CHEMMEDCHEM (2014)
DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis
Ataman Sendoel et al.
NATURE CELL BIOLOGY (2014)
Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain
Marco Sisignano et al.
NATURE REVIEWS NEUROLOGY (2014)
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma
James G. Gurney et al.
NEURO-ONCOLOGY (2014)
Inhibitors of Histone Deacetylases Enhance Neurotoxicity of DNA Damage
A. Vashishta et al.
NEUROMOLECULAR MEDICINE (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis
Thomas G. Hofmann et al.
BIOESSAYS (2013)
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Simon P. Wisnovsky et al.
CHEMISTRY & BIOLOGY (2013)
DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance
Maria A. Ermolaeva et al.
NATURE (2013)
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons
Matthew M. Dobbin et al.
NATURE NEUROSCIENCE (2013)
Laulimalide Induces Dose-Dependent Modulation of Microtubule Behaviour in the C. elegans Embryo
Megha Bajaj et al.
PLOS ONE (2013)
Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
Chengzhi Xie et al.
PLOS ONE (2013)
Chemotherapy-Related Cognitive Dysfunction
Jeffrey S. Wefel et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
Sherry L. Wolf et al.
SUPPORTIVE CARE IN CANCER (2012)
Chk1 has an essential role in the survival of differentiated cortical neurons in the absence of DNA damage
Weizhen Ye et al.
APOPTOSIS (2011)
Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent Mechanism
Chi Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
Shweta Kotian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
Andrew R. Burns et al.
NATURE CHEMICAL BIOLOGY (2010)
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Kyle M. Miller et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Chemotherapy-induced peripheral neuropathy: an unresolved issue
R. Velasco et al.
NEUROLOGIA (2010)
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy
Ruth Sittl et al.
NEUROTOXICOLOGY (2010)
Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer
Jennifer S. Temel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
Sushant K. Kachhap et al.
PLOS ONE (2010)
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats
Riejanne Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Targeting the DNA Damage Response in Cancer
Mats Ljungman
CHEMICAL REVIEWS (2009)
Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2
Nadja Bitomsky et al.
FEBS JOURNAL (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Role of MAPKs in platinum-induced neuronal apoptosis
Arianna Scuteri et al.
NEUROTOXICOLOGY (2009)
Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
Amelie Rebillard et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat
Alexia Kagiava et al.
NEUROTOXICOLOGY (2008)
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Richard C. Scarpulla
PHYSIOLOGICAL REVIEWS (2008)
The DNA damage response: Ten years after
J. Wade Harper et al.
MOLECULAR CELL (2007)
Repair capacity for Platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy
Anna Dzagnidze et al.
JOURNAL OF NEUROSCIENCE (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats
Anke Tomaszewski et al.
NEUROTOXICOLOGY (2007)
Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding
Lauren E. Ta et al.
NEUROTOXICOLOGY (2006)
High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity
Jan Peter Thomas et al.
MOLECULAR PHARMACOLOGY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra - Implications for Parkinson disease
J Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cell cycle activation linked to neuronal cell death initiated by DNA damage
II Kruman et al.
NEURON (2004)
Opinion - Transcription - guarding the genome by sensing DNA damage
M Ljungman et al.
NATURE REVIEWS CANCER (2004)
Superoxide dismutase mimetics elevate superoxide dismutase activity in vivo but do not retard aging in the nematode Caenorhabditis elegans
M Keaney et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling
A Mandic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
No increase in lifespan in Caenorhabditis elegans upon treatment with the superoxide dismutase mimetic EUK-8
M Keaney et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Acute transient encephalopathy after paclitaxel infusion:: report of three cases
CG Ziske et al.
ANNALS OF ONCOLOGY (2002)
Cisplatin stops tubulin assembly into microtubules. A new insight into the mechanism of antitumor activity of platinum complexes
AA Tulub et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
Functional genomic analysis of C-elegans chromosome I by systematic RNA interference
AG Fraser et al.
NATURE (2000)
Extension of life-span with superoxide dismutase/catalase mimetics
S Melov et al.
SCIENCE (2000)
Share Paper
